Ah battery in my campervan has limitations, and I must be wary of power usage in a way I didn’t have to be when living in an ...

Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe ...

Bristol-Myers Squibb's has become the first company to bring a cardiac myosin inhibitor through to FDA approval, claiming a green light from the US regulator for mavacamten as a therapy for ...

The market for wireless lighting controls is growing quickly as businesses and consumers move toward smarter, more energy-efficient spaces. Voice control integration is driving growth as advanced ...